JPMorgan initiates coverage on DowDuPont at an overweight rating on its cash generation potential.
*Unit could fetch around $4.4 billion- analyst. FRANKFURT/ COLOGNE, Sept 5- Germany's Merck KGaA is considering selling its consumer healthcare business which has sales of $1 billion a year to help fund more research into prescription drugs and amid declines in the company's separate liquid crystal business. Fully anticipating this, we are preparing strategic...
Solvay CFO Karim Hajjar speaks about his company's latest earnings and potential challenges it could face in the second half of 2017.
*Louis Dreyfus planning series of divestments. PARIS, July 24- Louis Dreyfus Company has agreed to sell its African fertilizer business to Helios Investment Partners, sealing the first of a series of divestments planned by Louis Dreyfus as it responds to a tough cycle for agricultural commodity traders. Helios, a private equity firm, is to acquire 100 percent of...
JPMorgan raises its rating on Chemours to overweight from neutral, saying earnings will beat expectations next year.
German drug and chemicals giant Bayer has made an unsolicited takeover offer for Monsanto, the world's biggest seed company.
The oil market is reaching some stability after earlier volatility, the vice chairman of Saudi petrochemicals giant SABIC said.
Karim Hajjar, CFO of Solvay, says oil and gas prices have impacted profits after reporting a slower rate of growth.
CNBC's Julia Chatterley reports from Basel on Syngenta and the takeover deal by ChemChina, a Chinese state-owned company.
ChemChina is nearing a deal to take over Syngenta for around $42 billion, two people familiar with the matter told Reuters.
Dow Chemical and DuPont are expected to announce a merger of equals by Thursday, sources told CNBC.
Dow reported a better-than-expected quarterly profit, helped by higher margins in five of its six units.
Stable, low oil prices are good because the drop in crude is supply-driven and will act as stimulus, Dow Chemical CEO Andrew Liveris tells CNBC.
DuPont reported a 52 percent jump in profit as operating margins rose in five of its seven businesses.
Investors seeking steady gains on innovation should look past tech buzz. When R&D productivity is measured, 'boring' stocks often lead.